Covered recipient · General Payments record
SARAH L VACCA
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,005.59
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $315.46 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $77.71 | 3 |
| Astellas Pharma US Inc | $55.67 | 2 |
| Otsuka America Pharmaceutical, Inc. | $25.00 | 1 |
| Merck Sharp & Dohme Corporation | $24.28 | 1 |
| Lundbeck LLC | $20.30 | 1 |
| Amgen Inc. | $19.89 | 1 |
| PFIZER INC. | $18.93 | 1 |
| ABBVIE INC. | $17.06 | 1 |
| Braeburn Inc. | $15.04 | 1 |
| Lilly USA, LLC | $14.34 | 1 |
| Indivior Inc. | $13.76 | 1 |
| SANOFI PASTEUR INC. | $13.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.06 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108343079 | CMS |
| Amgen Inc. | $19.89 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117706810 | CMS |
| Astellas Pharma US Inc | $24.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139473562 | CMS |
| Astellas Pharma US Inc | $30.71 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139558067 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.88 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104651317 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.76 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104420063 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.07 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104571138 | CMS |
| Braeburn Inc. | $15.04 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125622111 | CMS |
| Indivior Inc. | $13.76 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144574363 | CMS |
| Lilly USA, LLC | $14.34 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135960549 | CMS |
| Lundbeck LLC | $20.30 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146101905 | CMS |
| Merck Sharp & Dohme LLC | $24.28 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141972853 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.00 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119205337 | CMS |
| PFIZER INC. | $18.93 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131258997 | CMS |
| SANOFI PASTEUR INC. | $13.48 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128749931 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.